TY - JOUR
T1 - Smartphone-based Stroop Test, EncephalApp
T2 - What is the optimal cutoff for diagnosing minimal hepatic encephalopathy?
AU - Masuzaki, Ryota
AU - Kogure, Hirofumi
N1 - Publisher Copyright:
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
PY - 2025
Y1 - 2025
N2 - Jiang et al explored the diagnostic capabilities of EncephalApp, a smartphone-based Stroop Test, in patients with nonalcoholic liver disease. The study included 160 patients with nonalcoholic cirrhosis and utilized the psychometric hepatic encephalopathy score as a benchmark for diagnosing minimal encephalopathy. The identified optimal cutoff times were > 101.93 seconds for the “off” time and > 205.86 seconds for the combined “on + off” time, demonstrating sensitivities of 0.84 and 0.90, and specificities of 0.77 and 0.71, respectively. The findings suggest the necessity of employing different cutoffs for patients with alcoholic vs nonalcoholic liver cirrhosis, reflecting the distinct pathophysiologies underlying each condition. Additionally, alcohol consumption itself may influence Stroop test outcomes. Therefore, it is reasonable to establish separate benchmarks for alcoholic and nonalcoholic cirrhotic patients. Further validation in larger patient cohorts with clinical outcomes is essential. The demand for noninvasive liver disease assessments remains high in clinical practice.
AB - Jiang et al explored the diagnostic capabilities of EncephalApp, a smartphone-based Stroop Test, in patients with nonalcoholic liver disease. The study included 160 patients with nonalcoholic cirrhosis and utilized the psychometric hepatic encephalopathy score as a benchmark for diagnosing minimal encephalopathy. The identified optimal cutoff times were > 101.93 seconds for the “off” time and > 205.86 seconds for the combined “on + off” time, demonstrating sensitivities of 0.84 and 0.90, and specificities of 0.77 and 0.71, respectively. The findings suggest the necessity of employing different cutoffs for patients with alcoholic vs nonalcoholic liver cirrhosis, reflecting the distinct pathophysiologies underlying each condition. Additionally, alcohol consumption itself may influence Stroop test outcomes. Therefore, it is reasonable to establish separate benchmarks for alcoholic and nonalcoholic cirrhotic patients. Further validation in larger patient cohorts with clinical outcomes is essential. The demand for noninvasive liver disease assessments remains high in clinical practice.
KW - Alcohol-related liver disease
KW - Liver cirrhosis
KW - Metabolic dysfunction-associated liver disease
KW - Minimal encephalopathy
KW - Portal hypertension
KW - Stroop test
UR - http://www.scopus.com/inward/record.url?scp=105001205388&partnerID=8YFLogxK
U2 - 10.4254/wjh.v17.i3.101649
DO - 10.4254/wjh.v17.i3.101649
M3 - Article
AN - SCOPUS:105001205388
SN - 1948-5182
VL - 17
JO - World Journal of Hepatology
JF - World Journal of Hepatology
IS - 3
M1 - 101649
ER -